These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 15892194)
1. Implantable cardioverter-defibrillators. van Veldhuisen DJ; Voors AA N Engl J Med; 2005 May; 352(19):2022-5; author reply 2022-5. PubMed ID: 15892194 [No Abstract] [Full Text] [Related]
2. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials. Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408 [TBL] [Abstract][Full Text] [Related]
4. Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Everyone with an ejection fraction < or = 30% should receive an implantable cardioverter-defibrillator. Moss AJ Circulation; 2005 May; 111(19):2537-49; discussion 2537-49. PubMed ID: 15900623 [No Abstract] [Full Text] [Related]
5. Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Not everyone with an ejection fraction < or = 30% should receive an implantable cardioverter-defibrillator. Buxton AE Circulation; 2005 May; 111(19):2537-49; discussion 2537-49. PubMed ID: 15897357 [No Abstract] [Full Text] [Related]
6. Defibrillation threshold testing in implantable cardioverter-defibrillators: might less be more than enough? Curtis AB J Am Coll Cardiol; 2008 Aug; 52(7):557-8. PubMed ID: 18687250 [No Abstract] [Full Text] [Related]
8. [Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy]. Primo JJ Rev Port Cardiol; 2001 Feb; 20(2):225-8. PubMed ID: 11293882 [No Abstract] [Full Text] [Related]
9. Risk stratification for sudden death in heart failure. Farwell D; Gollob MH Minerva Cardioangiol; 2007 Jun; 55(3):379-84. PubMed ID: 17534256 [TBL] [Abstract][Full Text] [Related]
10. Sudden death prevention in heart failure. Machado M; Falcão LM; Ravara L Rev Port Cardiol; 2006; 25(7-8):727-62. PubMed ID: 17069438 [TBL] [Abstract][Full Text] [Related]
11. [Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy]. Spirito P; Piccininno M Ital Heart J Suppl; 2000 Jun; 1(6):840-1. PubMed ID: 11204022 [No Abstract] [Full Text] [Related]
12. Effective and efficient use of implantable defibrillators: sometimes it's over when it's over. Dorian P CMAJ; 2009 Mar; 180(6):599-600. PubMed ID: 19289799 [No Abstract] [Full Text] [Related]
13. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy. Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224 [TBL] [Abstract][Full Text] [Related]
15. Predicting outcome after implantable cardioverter-defibrillator therapy: a new piece to the puzzle? Shepard RK; Ellenbogen KA J Am Coll Cardiol; 2009 Aug; 54(9):829-31. PubMed ID: 19695462 [No Abstract] [Full Text] [Related]